Lenders extend deadlines for potential resolution under credit agreement
BioXcel Therapeutics lenders have amended their credit agreement to extend March 31 deadlines, now allowing for an acceptable transaction to be completed on or prior to August 28, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day